Dr. John Gerhardt Takes Stand on Range of Motion Claims; Puts End To Debate Over Superiority of MyoVision Technology. Read His Statement by clicking HERE.

Dr. John Gerhardt, the world's leading expert on Range of Motion testing, and author of the AMA Publication: "The Practical Guide to Range of Motion Assessment" writes letter to doctors regarding importance of using MyoVision Technology to obtain accurate, reproducible results.

 

ICA Joins Forces With MyoVision To Protect Your Right To Practice Through Use of Objective Documentation. View Video Of Announcement by clicking HERE.

 

According to ICA President Dr.John Maltby "Our technology review committee reviewed MyoVision and found it to be the finest product of its type,and we the ICA endorse MyoVision without reservation"

MyoVision is excited about this new alliance, as it furthers our goal of establishing the importance of instrumentation in documenting not only the need for care, but also using objective data to prove presence or absense of soft tissue injury or other spinal disorders. It also confirms what doctors around the globe have known for 19 years...that MyoVision is your best choice when it comes to selecting instrumentation.

For video of announcement click HERE.

 

World Famous sEMG Researcher Alex Ambroz, MD publishes yet another study utilizing the MyoVision. View the abstract by clicking here.

 

MyoVision Announces Strategic Alliance With Royal Cross,
The Most Respected Distributor in Canada

MyoVision is excited to announce that Royal Cross has been selected as the authorized Canadian representative to market, sell and distribute MyoVision products in Canada. Royal Cross is a Canadian owned corporation specializing in patient education and patient management systems. .

“We are pleased to announce our new alliance with MyoVision,” said Scott Spencer, President of Royal Cross.

Royal Cross is a leading supplier to the healthcare profession nationally in Canada. A consumable products oriented company, Royal Cross is partnered with some of the most prestigious suppliers in the chiropractic industry and provides an extensive line of patient education and management materials.

“MyoVision is dedicated to maintaining the highest standards and most technically advanced instrumentation for measuring soft tissue injury, patient management, and internal and external ethical marketing in the world.

"We are excited to establish this new relationship that will enhance the Chiropractic market in Canada,” said David Marcarian, designer and President of Precision Biometrics, manufacturer of the MyoVision. “MyoVision supports the chiropractic profession around the world and wants to take it to the next level in Canada."

The Royal Cross team has a reputation for excellence which matches MyoVision’s making this a true win-win relationship for our Canadian Customers.”

For more information about MyoVision products in Canada contact Royal Cross MyoVision Specialist, Bill Leonhardt at bill@royalcross.net or Call: 905-761-3278 (local) 1-800-461-0100 (toll free). www.royalcross.net

MyoVision Receives Major Endorsement From Author of AMA Publication: "The Practical Guide To Range Of Motion Assessment", Dr. John Gerhardt...read more

World Famous Whiplash Expert and Director Of Spine Research Institute Of San Diego, Dr. Art Croft, Publishes Case Study Utilizing MyoVision

MyoVision, Marcarian Win Major Superior Court Battle Vaildating MyoVision Technology; New Research Study Validates SEMG and MyoVision As The Best Technology. Click Here For Details

• Marcarian Influences ASHN's sEMG Policy, Thousands Benefit
• MyoVision Utilizes NIOSH recommended Silver / Silver Chloride Electrode
• Articles related to the case
• Court Cases / Legal Docs
• Seminar Events